Study the Novel Functions and Molecular Mechanisms of Vascular Endothelial Growth Factor-C (VEGF-C) in Acute Myeloid Leukemia (AML)
N/A
18 Years
60 Years
18 Years
60 Years
Open (Enrolling)
Both
Acute Myeloid Leukemia
Both
Acute Myeloid Leukemia
Trial Information
Study the Novel Functions and Molecular Mechanisms of Vascular Endothelial Growth Factor-C (VEGF-C) in Acute Myeloid Leukemia (AML)
Inclusion Criteria:
- patients who were diagnosed acute myeloid leukemia
Exclusion Criteria:
- patients who were diagnosed other type leukemia
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Principal Investigator
Ming-Hsien Chien
Investigator Role:
Principal Investigator
Investigator Affiliation:
Taipei Medical University
Authority:
Taiwan: Department of Health
Study ID:
99025
NCT ID:
NCT01195506
Start Date:
September 2010
Completion Date:
Related Keywords:
- Acute Myeloid Leukemia
- We Will Collect the Bone Marrow Specimens From AML Patients
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
Name | Location |
|---|
